eFFECTOR Therapeutics Inc - Units (1 Ord Share Class A & 1/3 War)
LWACU
Get informed when a big investor buys or sells
+ FollowMarket Cap$308.85M
Close$
Share Statistics
| Market cap | $308.85 Million |
|---|---|
| Enterprise Value | $308.38 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $0.12 |
| Beta | 0.08 |
| Outstanding Shares | 30,075,000 |
Return
| Return on Equity | 2.37% |
|---|---|
| Return on Assets | 2.29% |
| Return on Invested Capital | -0.27% |
Valuation & Multiples
| P/E Ratio | 26.23 |
|---|---|
| PEG | -4.75 |
| Price to Sales | - |
| Price to Book Ratio | 1.48 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -502.76 |
| Enterprise Value to Net Income | 60 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About eFFECTOR Therapeutics Inc
CEO: Steve Worland Locust Walk Acquisition Corp. is a blank-check company formed for the purpose of acquiring or merging with one or more businesses,